"To ensure medicines which fulfil valuable therapeutic needs are modernised and improved and remain available to patients"

Marlborough's intention is to make a series of acquisitions of niche medicines predominantly from larger pharmaceutical companies.

Such medicines may require resource and further development to meet modern regulatory and commercial standards.